SEC Company Response from INVIVO THERAPEUTICS HOLDINGS CORP. (CIK 0001292519) — Mar 3, 2020
INVIVO THERAPEUTICS HOLDINGS CORP. (CIK 0001292519)
Date: March 3, 2020 · CIK: 0001292519 · Accession: 0001104659-20-028575
AI Filing Summary & Sentiment
File numbers found in text: 333-236572
Letter
InVivo Therapeutics Holdings Corp.
One Kendall Square, Suite B14402
Cambridge, MA 02139
March 3, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: InVivo Therapeutics Holdings Corp.
Registration Statement on Form S-1
File No. 333-236572
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, InVivo Therapeutics Holdings Corp. hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-236572), so that it may become effective at 5:15 p.m. on March 5, 2020, or as soon thereafter as practicable.
[Remainder of Page Intentionally Left Blank]
Very truly yours,
INVIVO THERAPEUTICS HOLDINGS CORP.
Show Raw Text
CORRESP 1 filename1.htm InVivo Therapeutics Holdings Corp. One Kendall Square, Suite B14402 Cambridge, MA 02139 March 3, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: InVivo Therapeutics Holdings Corp. Registration Statement on Form S-1 File No. 333-236572 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, InVivo Therapeutics Holdings Corp. hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-236572), so that it may become effective at 5:15 p.m. on March 5, 2020, or as soon thereafter as practicable. [Remainder of Page Intentionally Left Blank] Very truly yours, INVIVO THERAPEUTICS HOLDINGS CORP. By: /s/ Richard Toselli Name: Richard Toselli Title: President and Chief Executive Officer Signature Page to Acceleration Request